The straight talk on immune deviation

Clinical Immunology and Immunopathology

Volumn 88, Issue 1, 1998, Pages 1-3

  Segal, B M ^a   Shevach, E M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; EDITORIAL; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031877111     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4559     Document Type: Editorial

References (23)

1. L.B. Nicholson J.M. Greer R.A. Sobel M.B. Lees V.K. Kuchroo An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis Immunity 3 1995 397 405
2. S.J. Khoury E. Akalin A. Chandraker L.A. Turka P.S. Linsley M.H. Sayegh W.W. Hancock CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system J. Immunol. 155 1995 4521 4524
3. R.A. Seder W.E. Paul Acquisition of lymphokine-producing phenotype by CD4+ T cells Annu. Rev. Immunol. 12 1994 635 673
4. S.S. Zamvil L. Steinman The T lymphocyte in experimental allergic encephalomyelitis Annu. Rev. Immunol. 8 1990 579 621
5. V. Navikas H. Link Review: Cytokines and the pathogenesis of multiple sclerosis J. Neurosci. Research 45 1996 322 333
6. M. Krakowski T. Owens Interferon-γ confers resistance to experimental allergic encephalomyelitis Eur. J. Immunol. 26 1996 1641 1646
7. D.O. Willenborg S. Fordham C.C.A. Bernard W.B. Cowden I.A. Ramshaw IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis J. Immunol. 157 1996 3223 3227
8. I.A. Ferber S. Brocke C. Taylor-Edwards W. Ridgway C. Dinisco L. Steinman D. Dalton C.G. Fathman Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental allergic encephalomyelitis (EAE) J. Immunol. 156 1996 5 7
9. K. Frei H-P. Eugster M. Bopst C.S. Constaninescu E. Lavi A. Fontana Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental encephalomyelitis J. Exp. Med. 185 1997 2177 2182
10. J. Liu M.W. Marino G. Wong D. Grail A. Dunn J. Bettadapura A.J. Slavin L. Old C.C.A. Bernard TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination Nature Med. 4 1998 78 83
11. K. Vermeire H. Heremans M. Vandeputte S. Huang A. Billiau P. Matthys Accelerated collagen-induced arthritis in IFNγ receptor-deficient mice J. Immunol. 158 1997 5507 5513
12. A. Billau H. Heremans F. Vandekerckhove R. Dijkmans H. Sobis E. Meulepas H. Carton Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ J. Immunol. 140 1998 1506 1510
13. J.A.C. Voorthius B.M. Uitdehaag C.J.A. DeGroot P.H. Goede P.H. Van der Meide C.D. Dijkstra Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-γ in Lewis rats Clin. Exp. Immunol. 81 1990 183 188
14. T.T. Duong F.D. Finkelman B. Singh G.H. Strejan Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains J. Neuroimmunol. 53 1994 101 107
15. J.J. Lafaille F. Van de Keere A.L. Hsu J.L. Baron W. Haas C.S. Raine S. Tonegawa Myelin basic protein-specific T helper 2 (Th2) cells cause experimental allergic encephalomyelitis in immunodeficient hosts rather than protect them from disease J. Exp. Med. 186 1997 307 312
16. S.V. Pakala M.O. Kurrer J.D. Katz T helper 2 (Th2) cells induce pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice J. Exp. Med. 186 1997 299 306
17. R. Liblau L. Steinman S. Brocke Experimental autoimmune encephalomyelitis in IL-4 deficient mice Int. Immunol. 9 1997 799 803
18. V.L. Perez J.A. Lederer A.H. Lichtman A.K. Abbas Stability of Th1 and Th2 populations Int. Immunol. 7 1995 869 875
19. B.M. Segal B.K. Dwyer E.M. Shevach An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease J. Exp. Med. 187 1998 537 546
20. S. Mocci R.L. Coffman Induction of a Th2 population from a polarized Leishmania J. Immunol. 154 1995 3779 3787
21. R.C. Van der Veen S.A. Stohlman Encephalitogenic Th1 T cells are inhibited by Th2 cells with related peptide specificity: Relative roles of interleukin (IL)-4 and IL-10 J. Neuroimmunol. 48 1993 213 220
22. M.K. Racke A. Bonomo D.E. Scott B. Cannella A. Levine C.S. Raine E.M. Shevach M. Rocken Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease J. Exp. Med. 180 1994 1961 1966
23. A. Khoruts S.D. Miller M.K. Jenkins Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells J. Immunol. 155 1995 5011 5017